VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
55 hedge funds and large institutions have $40.4M invested in Viracta Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
55
Holding in Top 10
1
Calls
$654K
Puts
$175K
Top Buyers
| 1 | +$4.49M | |
| 2 | +$2.04M | |
| 3 | +$1.89M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$1.12M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$781K |
Top Sellers
| 1 | -$2.49M | |
| 2 | -$567K | |
| 3 | -$305K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$274K |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$237K |